Latest News

Sunday, February 18, 2018

Dermira Presents Positive Data on Treating Pediatric Patients with Axillary Hyperhidrosis

Dermira, Inc. presented new findings from its glycopyrronium tosylate (formerly DRM04) Phase 3 clinical program showing that when applied topically, the investigational therapy improved disease severi…

Read the full story

Saturday, February 17, 2018

Estée Lauder Companies Anti-Aging Research On Skin Demonstrates Efficacy of Actives and Novel Technologies in Skin Research

The Estée Lauder Companies Research & Development (R&D) presented research focused on new findings in anti-aging skin research at the 2018 American Academy of Dermatology Annual Meeting…

Read the full story

Friday, February 16, 2018

Ortho Dermatologics Presents Analysis of Siliq Phase 3 Data on Disease-Related Anxiety and Depression in Patients with Psoriasis

Ortho Dermatologics, a division of Valeant Pharmaceuticals North America, LLC, shared the results from an analysis of the Phase 3 clinical trial AMAGINE-1, which evaluated mental health comorbidities …

Read the full story

Friday, February 16, 2018

Meet the Newest AAD Officers and Board Members

Suzanne M. Olbricht, MD, FAAD, a Boston-based dermatologist, will take the helm of the American Academy of Dermatology (AAD) as the new President. Her one-year term officially begins on Tuesday, Feb. …

Read the full story

Friday, February 16, 2018

Exciplex Phototherapy Device Debuts at AAD 2018

Excimer Therapies Inc.,  now has the exclusive U.S. distribution rights for the Clarteis SAS exciplex® phototherapy treatment device. Excimer Therapies officially enters the market and wil…

Read the full story

Friday, February 16, 2018

Some Parents Just Don’t Understand Risks of Indoor Tanning

Dads, parents who had used indoor tanning devices themselves and those who reported that they had never received skin cancer prevention counseling from their child’s doctor are less likely to be…

Read the full story

Friday, February 16, 2018

Merkel Cell Carcinoma Is On The Rise

Merkel cell carcinoma (MCC) is on the rise, according to new research published in the Journal of the American Academy of Dermatology and presented at the American Academy of Dermatology 201…

Read the full story

Friday, February 16, 2018

Stelara Reduces Aortic Vascular Inflammation

In addition to its effects on skin inflammation, Stelara (Ustekinumab) reduces aortic inflammation, report researchers from the Perelman School of Medicine at the University of Pennsylvania …

Read the full story

Thursday, February 15, 2018

Restoration Robotics to Showcase ARTAS Robotic Hair Restoration System at Annual AAD Meeting

Restoration Robotics, Inc. will showcase the ARTAS Robotic Hair Restoration System at The Annual Meeting of the American Academy of Dermatology (AAD) February 15-18 at the San Diego Convention Center …

Read the full story

Thursday, February 15, 2018

FDA Grants Priority Review for Genentech’s Rituxan for Pemphigus Vulgaris

The FDA has accepted Genentech’s Supplemental Biologics License Application (sBLA) and granted Priority Review for the use of Rituxan (rituximab) for the treatment of pemphigus vulgaris (PV). Ge…

Read the full story

Thursday, February 15, 2018

Aqua Pharmaceuticals Supports Camp Discovery

  Aqua Pharmaceuticals, LLC is demonstrating its commitment to the dermatology community by supporting American Academy of Dermatology’s Camp Discovery and is making a donation up to $5,…

Read the full story

Thursday, February 15, 2018

Lilly: New Taltz Data and Pipeline Update to be Presented at AAD Annual Meeting

Eli Lilly and Company will present new data for Taltz® (ixekizumab), baricitinib, and mirikizumab at the American Academy of Dermatology (AAD) annual meeting in San Diego. The data include…

Read the full story

Wednesday, February 14, 2018

Zylö Therapeutics: Adam Friedman, MD to Present Data at AAD Annual Meeting

Zylö Therapeutics, a nanotechnology-based biopharmaceutical company dedicated to bringing innovative technologies to multiple facets of medicine, announced that preclinical data, utilizing Zyl&ou…

Read the full story

Wednesday, February 14, 2018

NanOlogy Enrolls First Patient in Clinical Trial for Cutaneous Metastases

NanOlogy™, a clinical-stage pharmaceutical development company and affiliate of DFB Pharmaceuticals, has enrolled the first patient in a Phase 1/2 clinical trial of a submicron particle paclitax…

Read the full story

Wednesday, February 14, 2018

Lumenis to Introduce PicoFractional Technology at AAD Annual Meeting

 Lumenis Ltd. plans to unveil the Pico Fractional, a new photoacoustic fractional laser, at the American Academy of Dermatology (AAD) Annual Meeting in San Diego, CA from February 16th-18th, 2018…

Read the full story
Load More